Skip to content
Kanna is the best-known common name for a South African succulent long used in Indigenous traditions for mood, stress, social connection, thirst, and endurance. Most modern supplement labels and clinical papers call the plant Sceletium tortuosum, but current Kew taxonomy accepts Mesembryanthemum tortuosum L. and treats Sceletium tortuosum as a botanical synonym. Both names matter: one is the current accepted name, while the other remains deeply established in ethnobotanical, commercial, and clinical literature.
Botanical Identity
Common names: kanna, channa, kougoed, kou-goed, sceletium
Current accepted botanical name: Mesembryanthemum tortuosum L.
Widely used synonym: Sceletium tortuosum (L.) N.E.Br.
Family: Aizoaceae
Kew lists the species as native to South Africa's Cape Provinces, where it grows as a succulent subshrub in dry shrubland and desert-associated habitat. Kew's Medicinal Plant Names Services records “kanna” and related names in African herbal and commercial medicinal sources.
Traditional South African Use
Kanna is closely associated with the traditional knowledge of Khoekhoe and San peoples of southern Africa. Historical records describe plant material being used in social, ceremonial, and practical settings and for effects associated with mood, calming, hunger or thirst, and endurance. Traditional preparations varied, and the historical record has been complicated by colonization, loss of land, disruption of Indigenous knowledge systems, and later commercialization.
A responsible modern account should recognize that kanna did not begin as a Western “nootropic” or mood supplement. Its commercial reputation grew from much older southern African knowledge.
Key Alkaloids
Kanna contains a group of alkaloids that includes mesembrine, mesembrenone, mesembrenol, and mesembranol, along with other related compounds. Alkaloid profiles vary among plants, growing conditions, plant material, and manufactured extracts.
Laboratory research has found that standardized kanna extracts can inhibit the serotonin transporter and phosphodiesterase-4, or PDE4. Mesembrine is particularly active at the serotonin transporter, while mesembrenone has activity at both serotonin transport and PDE4 targets. These mechanisms help explain why researchers have investigated kanna for stress, mood, and cognition.
What Human Research Shows
The modern human evidence is still small and is based mainly on standardized extracts in healthy volunteers, not on large trials in people diagnosed with anxiety or depressive disorders.
A randomized, double-blind, placebo-controlled safety study tested standardized extract in healthy adults for three months and found it generally well tolerated at the studied doses. Another small randomized crossover trial in 21 cognitively healthy adults reported improvements in selected measures of cognitive flexibility and executive function after three weeks of a standardized extract, along with some positive mood and sleep findings.
A later experiment involving 20 healthy young volunteers examined laboratory-induced stress and anxiety. One of two experimental tasks showed lower subjective anxiety with the standardized extract, while the other did not show a treatment effect. The researchers described the evidence as tentative rather than conclusive.
What the Evidence Does Not Show
Kanna has not been established as a replacement for treatment of major depression, anxiety disorders, trauma-related disorders, dementia, or other psychiatric or neurologic conditions. Reviews repeatedly note that the clinical studies are small, often involve healthy participants, and frequently use a specific proprietary standardized extract. Results from one standardized product cannot automatically be applied to every dried herb, tincture, powder, chew, or supplement sold as kanna.
Serotonin and Medication Caution
The serotonin-transporter activity that makes kanna scientifically interesting also creates an important caution. Because laboratory studies show serotonergic activity, combining concentrated kanna products with medicines or supplements that strongly affect serotonin—including antidepressants such as SSRIs, SNRIs, and MAO inhibitors—should not be assumed safe. Direct human interaction research is limited.
People using psychiatric medicines, stimulant medicines, sedatives, or multiple centrally acting drugs should discuss kanna with a qualified healthcare professional or pharmacist before using a concentrated extract. A traditional history of use does not eliminate modern drug-interaction questions.
Pregnancy, Breastfeeding, and Children
There is not enough reliable human safety information to support medicinal kanna use during pregnancy, breastfeeding, or childhood. Concentrated extracts are best avoided in these groups unless a qualified clinician specifically recommends otherwise.
Product Quality Matters
Kanna supplements can differ dramatically in species identity, alkaloid content, extraction method, and standardization. Much of the human research has used a defined proprietary extract with a controlled alkaloid profile. A generic product labeled only “kanna” may not match the material studied.
The botanical-name issue adds another layer: modern scientific databases may use Mesembryanthemum tortuosum, while supplement labels and research papers often continue to use Sceletium tortuosum. A trustworthy label should make the identity clear rather than hiding behind a common name alone.
Conservation and Cultural Respect
Kanna is native to a limited part of southern Africa and has experienced commercial harvesting pressure. Kew's current global plant-risk prediction system flags Mesembryanthemum tortuosum as having a predicted threatened extinction risk, though that prediction is not the same as a formal IUCN Red List assessment.
Responsible sourcing should therefore consider legal cultivation, traceability, sustainable harvest, and the Indigenous knowledge history that made the plant commercially valuable in the first place.
The Bottom Line
Kanna is a culturally important South African medicinal succulent with distinctive mesembrine-type alkaloids and an intriguing modern research record. Small human studies of standardized extracts suggest possible effects on selected measures of stress, anxiety, mood, and cognition, but the evidence remains preliminary and is based largely on healthy volunteers. Current taxonomy accepts the plant as Mesembryanthemum tortuosum, while Sceletium tortuosum remains the familiar research and commercial name. Because the plant affects serotonin-related pathways, medication interactions deserve particular caution.
This article is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent psychiatric, neurologic, or other disease.